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Monosomy for the X chromosome in humans creates a genetic Achilles’ heel for nature to deal with. We report
that the human X chromosome appears to have one-third the density of the coding sequence of the autosomes
and, because of partial shielding from the high mutation rate of the male sex, that it should also have a lower
mutation rate than the autosomes (i.e., .73). Hence, the X chromosome should contribute one quarter (.33#
) of the deleterious mutations expected from its DNA content. In this way, selection has possibly moderated.73 = .24
risks from mutation in X-linked genes that are thought to have been fixed in their syntenic state since the onset
of the mammalian lineage. The unexpected difference in the density of coding sequences indicates that our recent,
hemophilia B–based estimate of the rate of deleterious mutations per zygote should be increased from 1.3 to 4
( ).1.3# 3
Intuitively, the rate of mutations per genome seems likely
to be determined by a trade-off between the benefits of
reducing the deleterious mutation rate and the cost of
increasing fidelity.
The mammalian X chromosome could make an ex-
cessive contribution to the yield of deleterious mutations
because of monosomy in males. Hence, McVean and
Hurst (1997) proposed that selection would favor a
lower mutation rate on the X chromosome and pre-
sented supporting data from mouse- and rat-sequence
divergence. In birds, however, results were obtained that
were inconsistent with this hypothesis (Ellegren and Fri-
dolfsson 1997).
The idea of chromosome-specific mutation rates is not
very attractive, because DNA sequence fidelity relies on
general properties of replication, damage repair, and cel-
lular checkpoints that monitor the integrity and suc-
cessful replication of DNA during mitotic or meiotic cell
cycles.
Nature could moderate the X-chromosome yield of
deleterious mutations in other ways—for example, by
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ensuring that this chromosome has a small target for
deleterious mutations per megabase of DNA. Chromo-
somal gene content does not seem strictly proportional
to size, since (1) the phenotypic effects of trisomies are
not a simple function of chromosome length (Jacobs and
Hassold 1995); (2) dramatic interspecies differences ex-
ist in genome size (e.g., bp in humans and93# 10
bp in Fugu [Brenner et al. 1993]), relative to84# 10
gene number; (3) chromosomes vary in the content of
DNA isochores associated with gene richness (Bernardi
1989); and (4) chromosome paint for CpG islands,
which mark ∼60% of genes (Antequera and Bird 1993),
suggests a deficit in the human X chromosome (Craig
and Bickmore 1994). These considerations prompted us
to ask whether, on average, human X-linked genes show
a smaller (than autosomal) ratio of coding to noncoding
DNA.
We searched databases (GenBank and Integrated X
Chromosome Database) for human X-linked genes with
at least one autosomal homologue and known genomic
and mRNA structure. Only groups of genes with identity
35% throughout the length of encoded proteins were
considered.
Table 1 shows that a majority of X-linked genes are
larger than their autosomal homologues, despite similar
exon numbers. Some genes show similar base compo-
sition, and others show different levels of GC richness.
AT-rich genes are usually larger than their GC-rich
homologues. On average, the X-linked genes available
for comparison are threefold larger than their autosomal
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Table 1
Structure of X-Linked Genes and Their Autosomal Homologues
X-LINKED GENE AUTOSOMAL HOMOLOGUE
Name
No. of
Exons
mRNA
(kb)
Size
(kb)
Genomic GC/
mRNA GC
(%) Name
No. of
Exons
mRNA
(kb)
Size
(kb)
Genomic GC/
mRNA GC
(%)
AVPR 3 1.6 2 65/65 OXYR 4 4.1 18.9 ?/49
GUCY 20 3.7 109 40/47 GUCY2D 20 3.6 12.8 61/65
PDK3 10 1.6 40 40/43 PDK4 11 1.8 10.6 36/46
PLS3 16 1.7 ∼90 ?/42 LCP1 16 1.9 ∼90 ?/46
F9 8 2.8 34 39/39 F10 8 2.5 ∼25 ?/59
F7 8 2.5 12 61/59
PRTC 8 1.8 9 58/60
F8C 26 9 196 ?/42 F5 25 6.7 ∼72 ?/45
COL4A5 51 6.7 250 36/50 COL4A1 52 5 ∼100 ?/60
COL4A6 46 6.4 ∼425 ?/56
DMD 79 14 ∼2,400 ?/42 UTRN ? 13 ∼900 ?/45
SLC6 13 3.7 8.6 65/62 SLC6A11 16 2 ∼25 ?/56
SLC6A2 14 1.9 45 ?/57
TBG 5 1.8 5.2 41/43 P14 4 1.3 6.1 48/53
TIMP1 5 .8 ∼3 ?/58 TIMP2 5 1 ∼83 ?/65
TIMP3 5 4.6 61 ?/49
Average 4.48 296.9 3.58 98.0
Table 2
Coding Sequence in X-Chromosome and Chromosome-22
Regions Examined at the Sanger Centre
CHROMOSOME
X 22 X:22 RATIO
Finished sequence (Mb) 39.8 22.7 1.75
No. of exons 752 1,405 .535
Sum of exon length (bp) 153,603 223,730 .686
Sequence ratio (total:exon) 259 101 2.55
homologues. There are still few informative genes, but
the X-chromosome and autosomal sequences available
provide further data.
The sequence of chromosome 22 was announced re-
cently (Dunham et al. 1999), and much of the X chro-
mosome has been sequenced. Using AceBrowser, we ex-
amined the 22.7 Mb of chromosome 22 and the 39.8
Mb of the X chromosome, sequenced and annotated
using identical criteria at the Sanger Centre. This showed
752 and 1,405 exons (pseudogenes and noncoding exons
were excluded) in the X-chromosome and chromosome
22 sequences (table 2). The latter showed 2.55 times
more coding information per megabase than the former,
in keeping with the data on the aforementionedX-linked
and homologous autosomal genes. Hence, the X chro-
mosome appears to have a lower gene density and should
yield fewer deleterious mutations per megabase of DNA.
This contrasts with the suggestion by Cooper and Schi-
mtke (1984), who noted a lower level of RFLP hetero-
zygosity on the X chromosome, relative to the auto-
somes, and who suggested that this might be explained
by the X chromosome being particularly rich in coding
and regulatory sequences.
The sequence variation observed by the authors of
these earlier reports is expected to be essentially neutral,
and a better explanation for the low level of “neutral”
sequence variations on the X chromosome arises from
consideration of the joint consequences of the two fol-
lowing facts. There are only three X chromosomes, ver-
sus four of each type of autosome, so that a site on the
X chromosome has three fourths the chance of mutating
of a site on an autosome. The X chromosome spends
only one-third of its time in males, versus half for the
autosomes. Therefore, the overall mutation rate of the
X chromosome should be lower than that of the auto-
somes, when the male:female ratio of mutation rates is
11. Using data from the U.K. hemophilia B population,
we have directly estimated (Green et al. 1999) that this
ratio is 8.6, and, consequently, the human X-chromo-
some mutation rate should be 27% lower than that of
autosomes {[1 (2 8.6)# 2/(1 8.6)# 3]# 100 =
. In addition, background selection against recessive27}
deleterious mutatins will further reduce the frequency of
neutral variation on the X chromosome relative to au-
tosomes (Charlesworth 1994).
Ohno (1967) has presented compelling arguments to
suggest that the development of an X-Y sex-chromo-
some dimorphism and the device of X inactivation to
achieve dosage compensation have constrained the ev-
olution of the X chromosome in the mammalian line-
ages, so that its gene composition, in contrast to that of
individual autosomal pairs, has been conserved. It fol-
lows from this—now known as Ohno’s law—that the
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X chromosome has not been able to escape the selective
pressures mentioned at the outset of this report, by re-
ducing or substantially changing its gene content during
the evolution of the mammalian lineage.
The mammalian method of X-linked gene-dosage
compensation results in the activity of only one X chro-
mosome in female somatic cells from early embryonic
life (Lyon 1998). It follows that, uniquely in mammals
(Lucchesi 1998), even females are exposed to some risk
from X-linked gene hemizygosity. This further increases
the pressure of purifying selection. A small target for
deleterious mutations in the X chromosome thus seems
appropriate.
Lyon (1998) reviewed evidence on the spreading of
X inactivation and proposed that this is favored by in-
terspersed repetitive elements of the LINE (long inter-
spersed repeat-sequence element) type that may have ac-
cumulated in the X chromosome under the influence of
selection. Hence, a single process may have favored X
inactivation and low target density for deleterious
mutations.
In view of the lower density (.33) of coding sequences
that we found on the X chromosome and the lower X-
chromosome mutation rate resulting from the highmale:
female ratio of mutation rates ( ), we pro-1 .27 = .73
pose that the rate of deleterious mutations per megabase
of X chromosome should be only one quarter (.73#
of that per autosomal megabase..33 = .24)
Recently, we suggested that a human zygote carries
128 new mutations, of which 1.3 are deleterious or, ac-
cording to our definition, capable of causing clinically
detectable effects in the hemizygous state (Giannelli et
al. 1999). We based our calculations on data from X-
linked hemophilia B but did not take into account the
X chromosome’s threefold-lower target density for del-
eterious mutations. Therefore, a value of four deleterious
mutations (i.e., ) per human zygote is more1.3# 3.3
appropriate. Such a rate suggests that the continued ex-
istence of our species probably depends on quasi-trun-
cating selection and recombination, to allow elimination
of chromosomal regions carrying deleterious mutations
(Kondrashov 1988; Crow 1997).
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